From laboratory to arm – how the Oxford vaccine is created
From laboratory to arm – how the Oxford vaccine is created A team combatting 'Disease X' in Oxford, a glass vial plant in Wales, and safety checks in Hertfordshire 6 January 2021 • 1:36pm Some 530,000 doses of the vaccine became available across the UK from January 4, with vulnerable groups already identified as the priority for immunisation On Monday, six NHS Trusts began administering the Oxford-AstraZeneca vaccine to vulnerable people. It followed months of trials in which 11,500 volunteers from the UK and Brazil received the vaccine, and which found it to be 70.4 per cent effective ...